Colin Flaveny

Colin Flaveny is a highly experienced professional in the field of oncology and molecular toxicology. Currently serving as a Director and Principal Scientist at Pfizer since May 2021, Colin previously held the position of Assistant Professor at Saint Louis University from June 2015 to May 2021. Academic training includes postdoctoral studies in Oncology and Cancer Biology at both Scripps Research (2012-2013) and the University of Miami Miller School of Medicine (2010-2012). Colin earned a Ph.D. in Molecular Toxicology from Penn State University (2004-2010) and a Bachelor’s Degree in Biology from Howard University (2000-2003).